Compare AXON & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AXON | ZTS |
|---|---|---|
| Founded | 1993 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ordnance And Accessories | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.6B | 32.5B |
| IPO Year | 2001 | 2012 |
| Metric | AXON | ZTS |
|---|---|---|
| Price | $610.88 | $75.43 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 12 |
| Target Price | ★ $758.80 | $154.18 |
| AVG Volume (30 Days) | 889.6K | ★ 5.4M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.86% |
| EPS Growth | N/A | ★ 10.05 |
| EPS | 2.41 | ★ 3.08 |
| Revenue | $2,779,536,000.00 | ★ $9,467,000,000.00 |
| Revenue This Year | $31.50 | $5.63 |
| Revenue Next Year | $28.95 | $4.77 |
| P/E Ratio | $252.07 | ★ $25.17 |
| Revenue Growth | ★ 33.47 | 2.28 |
| 52 Week Low | $339.01 | $71.00 |
| 52 Week High | $792.16 | $156.49 |
| Indicator | AXON | ZTS |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 51.39 |
| Support Level | N/A | $73.02 |
| Resistance Level | N/A | $78.74 |
| Average True Range (ATR) | 0.00 | 2.26 |
| MACD | 0.00 | 0.35 |
| Stochastic Oscillator | 0.00 | 71.03 |
Axon Enterprise Inc is building a public safety operating system by integrating a suite of hardware devices and cloud software solutions. The company's suite includes cloud-hosted digital evidence management solutions, TASER energy devices, drones and robotic security, and training solutions. Its operation comprises of two operating segments, Software and Services, and Connected Devices. The company generates the majority of its revenue from the Connected Devices segment, which is engaged in developing, manufacturing, and selling fully integrated hardware solutions such as conducted energy devices sold under the TASER brand, body cameras, fixed and in-car cameras, drone and counter-drone technologies, and a broad ecosystem of accessories, extended warranties and related hardware products.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.